Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Call for Abstracts
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Call for Abstracts
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal
  • Twitter
  • Facebook
  • YouTube
Meeting ReportAerosol and Oxygen Therapy

Assessments of Aerosol Delivery and Fugitive Aerosol Particle Concentrations Generated During Aerosol Delivery via Two High-Flow Nasal Cannula Devices: A Randomized Crossover Study in Healthy Volunteers

Amnah A Alolaiwat, Lauren Harnois, Jie Li and James B Fink
Respiratory Care October 2021, 66 (Suppl 10) 3611391;
Amnah A Alolaiwat
Respiratory Care, Rush University Medical Center, Chicago, Illinois, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Harnois
Respiratory Care, Rush University Medical Center, Chicago, Illinois, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Li
Respiratory Care, Rush University Medical Center, Chicago, Illinois, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James B Fink
Respiratory Care, Rush University Medical Center, Chicago, Illinois, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • References
  • Info & Metrics
Loading

Abstract

Background: Aerosol delivery via high-flow nasal cannula (HFNC) has attracted clinical interest in recent years. Both HFNC and aerosol therapy have been considered as aerosol generating procedure (AGP) during COVID-19 pandemic. However, little is known about the fugitive aerosol concentrations during trans-nasal aerosol delivery and the effective method to reduce the fugitive aerosol concentrations.

Methods: After approval by the ethic committee in Rush University (20121804-IRB01), 7 healthy volunteers were consented and enrolled in the study. Two HFNC devices (Airvo2 and Vapotherm) were utilized with a vibrating mesh nebulizer (VMN) placed at the inlet of humidifier. Aerosol particle concentrations were compared between the two devices, in a random order of HFNC alone, HFNC with a surgical mask, HFNC with a scavenger face tent, HFNC with VMN, HFNC with VMN and a surgical mask, and HFNC with VMN and a scavenger face tent. HFNC flow was set at the highest level subject could tolerate, and 3mL of saline was placed in VMN for each nebulization. This study was implemented in an ICU room, with 2 aerosol particle sizers placed at 1 and 3 feet away from subjects to measure the fugitive aerosol concentrations at sizes of 0.3 to 10 µm at baseline, before, during and after each experiment. Furthermore, a small in-vitro study was conducted to evaluate inhaled dose with albuterol (2.5mg in 3mL) delivered using VMN via the two HFNC devices, three flow settings (20L, 40L, 60L for Airvo2 and 20L, 30L, 40L for Vapotherm) were used.

Results: Compared to baseline, both HFNC devices alone did not generate higher aerosol concentrations at all particle sizes. Compared to HFNC alone, nebulization via VMN with Vapotherm device did not generate higher fugitive aerosol concentrations (P > 0.05 for all particle sizes). In contrast, nebulization via VMN with Airvo2 device generated higher fugitive aerosol concentrations at sizes 0.3 to 1.0 µm. Placing a surgical mask or using a scavenger face tent were similar effective in reducing the fugitive aerosol concentrations (Figure 1). In the in-vitro study, the inhaled dose of albuterol was higher with VMN via Airvo2 than Vapotherm with HFNC flow of 20 L ([12.9 ± 0.9]% vs [1.3 ± 0.1]%, P = .05 ) and 40 L ([5.0 ± 0.2]% vs [0.8 ± 0.1]%, P = .05) (Table 1).

Conclusions: During aerosol delivery via HFNC, Airvo2 generated higher inhaled dose and fugitive aerosol particle concentrations than Vapotherm. Placing a surgical mask or a scavenger face tent could reduce fugitive aerosol concentrations.

View this table:
  • View inline
  • View popup
Table 1

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Footnotes

  • Commercial Relationships: This study was supported by an unrestricted research funding from Aerogen Ltd. Dr. Li discloses relationship with Fisher & Paykel Healthcare Ltd, Aerogen Ltd, and Rice Foundation and American Association for Respiratory Care. Dr. Fink discloses relationship with Aerogen Pharma Corp. Other authors have no conflict of interest to disclose.

  • Support: This study was supported by an unrestricted research funding from Aerogen Ltd. Dr. Li discloses relationship with Fisher & Paykel Healthcare Ltd, Aerogen Ltd, and Rice Foundation and American Association for Respiratory Care. Dr. Fink discloses relationship with Aerogen Pharma Corp.

  • Copyright © 2021 by Daedalus Enterprises
PreviousNext
Back to top

In this issue

Respiratory Care
Vol. 66, Issue Suppl 10
1 Oct 2021
  • Table of Contents
  • Index by author

 

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessments of Aerosol Delivery and Fugitive Aerosol Particle Concentrations Generated During Aerosol Delivery via Two High-Flow Nasal Cannula Devices: A Randomized Crossover Study in Healthy Volunteers
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Assessments of Aerosol Delivery and Fugitive Aerosol Particle Concentrations Generated During Aerosol Delivery via Two High-Flow Nasal Cannula Devices: A Randomized Crossover Study in Healthy Volunteers
Amnah A Alolaiwat, Lauren Harnois, Jie Li, James B Fink
Respiratory Care Oct 2021, 66 (Suppl 10) 3611391;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Assessments of Aerosol Delivery and Fugitive Aerosol Particle Concentrations Generated During Aerosol Delivery via Two High-Flow Nasal Cannula Devices: A Randomized Crossover Study in Healthy Volunteers
Amnah A Alolaiwat, Lauren Harnois, Jie Li, James B Fink
Respiratory Care Oct 2021, 66 (Suppl 10) 3611391;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References

Related Articles

Cited By...

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board
  • Reprints/Permissions

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire